Publication: Clinical Characteristics and Co-morbidities in Patients with Psoriatic Arthritis
| creativeworkseries.issn | ISSN 2091-0231 eISSN 2091-167X | |
| dc.contributor.author | Paudyal, Buddhi Prasad | |
| dc.contributor.author | Gyawalee, M | |
| dc.date.accessioned | 2025-08-21T09:01:17Z | |
| dc.date.available | 2025-08-21T09:01:17Z | |
| dc.date.issued | 2017 | |
| dc.description | Buddhi Prasad Paudyal Patan Academy of Health Sciences, Lalitpur M Gyawalee Patan Academy of Health Sciences, Lalitpur | |
| dc.description.abstract | Abstract: Introduction: Psoriatic Arthritis (PsA) is a chronic inflammatory arthritis and occurs in association with psoriasis, a chronic recurring and disfiguring skin disease. There is increasing recognition that both conditions are associated with multitude of co-morbidities. Objective: To delineate the clinical characteristics and co-morbidities in PsA patients attending a rheumatology clinic in Kathmandu valley. Material and Methods: Patients with already developed psoriasis who were seeking medical attention for arthritis during the period between January 2013 to December 2015 were prospectively enrolled. Patients were evaluated both by a dermatologist and a rheumatologist. A structured format was used to record relevant clinical information on psoriasis, PsA, and co-morbidities. Results: Among 55 patients with PsA, all were found to have plaque psoriasis mainly affecting extensor surfaces (64%), multiple areas (16%), and scalp (11%). Nail involvement was observed in 22% of patients. Symmetric polyarthritis was the most frequent (26%) form, followed by oligoarthrtis (18%), distal interphalangeal (DIP) joint arthritis (16%), spondyloarthritis (13%), and enthesitis-dactylitis (7%). Two thirds of patients were either overweight or obese. Almost half (47%) were current or past smokers. Diabetes or pre-diabetes was observed in 7% of cases. Hypertension, hyperlipidemia and ischemic heart disease (IHD) were present in 20%, 16%, and 5% respectively. Fatty liver disease was observed in 13% of the tested patients and 15% of patients were on some psychotropic drugs. Conclusion: Psoriasis with PsA was associated with both cardiovascular and non-cardiovascular co-morbidities. Doctors treating patients with these disorders should consider associated co-morbidities for better patient outcome. Keywords: psoriatic arthritis, co-morbidities, Nepal | |
| dc.identifier | https://doi.org/10.3126/njdvl.v15i1.18052 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/1898 | |
| dc.language.iso | en_US | |
| dc.publisher | Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON) | |
| dc.title | Clinical Characteristics and Co-morbidities in Patients with Psoriatic Arthritis | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Original Article | |
| oaire.citation.endPage | 43 | |
| oaire.citation.startPage | 39 | |
| relation.isJournalIssueOfPublication | ae585fa2-96f9-4b83-8b04-b8efd69bfc01 | |
| relation.isJournalIssueOfPublication.latestForDiscovery | ae585fa2-96f9-4b83-8b04-b8efd69bfc01 | |
| relation.isJournalOfPublication | b2ab7aab-75b0-4bd1-9ed0-b8a91c68201a |